ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Anchiano Therapeutics Ltd

Anchiano Therapeutics Ltd (ANCN)

4.71
0.00
(0.00%)
Closed August 24 4:00PM
0.00
0.00
(0.00%)

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
4.71
Bid
5.10
Ask
5.15
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Market Cap
Previous Close
4.71
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
-
Shares Outstanding
-
Dividend Yield
-
PE Ratio
0.00
Earnings Per Share (EPS)
-
Revenue
-
Net Profit
-24.22M

About Anchiano Therapeutics Ltd

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Headquarters
Tel Aviv, Center, Isr
Founded
1970

ANCN Latest News

Anchiano Announces Shareholder Approval of the Merger with Chemomab and Prices $45.5M Private Financing

Anchiano shareholders approve all resolutions at shareholder meeting The merged company is expected to receive approximate gross proceeds from the private financing of $45.5 million, which will...

Anchiano Therapeutics and Chemomab Announce Entry Into Definitive Merger Agreement

Merger brings lead compound CM-101, a first in class anti-CCL24 antibody into advanced clinical development for fibrosis-related diseases with significant unmet medical need Concurrent PIPE...

Anchiano Therapeutics Initiates Process to Voluntarily Delist its Ordinary Shares from the Tel Aviv Stock Exchange

CAMBRIDGE, Mass., March 14, 2019 (GLOBE NEWSWIRE) -- Anchiano Therapeutics Ltd. (Nasdaq and TASE: ANCN) (β€œAnchiano”) today announced an update with respect to its intention to voluntarily...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000DR
40000000DR
120000000DR
260000000DR
520000000DR
1560000000DR
2600000000DR

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
PRTGPortage Biotech Inc
$ 5.90
(118.49%)
49.67M
MNTSMomentus Inc
$ 1.04
(80.65%)
231.74M
GHSIGuardion Health Sciences Inc
$ 17.91
(58.50%)
561.42k
RETOReTo Eco Solutions Inc
$ 1.591
(52.98%)
3.45M
HUBCWHub Cyber Security Ltd
$ 0.0149
(40.57%)
40.79k
UBXGU BX Technology Ltd
$ 2.38
(-92.54%)
35.79M
FAMIFarmmi Inc
$ 0.2336
(-58.76%)
14.1M
GDCGD Culture Group Ltd
$ 5.43
(-29.94%)
28.75M
NUWENewellis Inc
$ 1.26
(-26.74%)
754.69k
TGLTreasure Global Inc
$ 0.85
(-25.44%)
1.4M
NVDANVIDIA Corporation
$ 129.37
(4.55%)
323.23M
MNTSMomentus Inc
$ 1.04
(80.65%)
231.74M
SQQQProShares UltraPro Short QQQ
$ 7.98
(-3.16%)
186.3M
MULNMullen Automotive Inc
$ 0.3321
(-7.62%)
140.97M
APDNApplied DNA Sciences Inc
$ 2.4901
(36.07%)
127.34M

ANCN Discussion

View Posts
dinogreeves dinogreeves 3 years ago
ANCN will hit 12-15 tomorrow. Good luck.
πŸ‘οΈ0
ClayTrader ClayTrader 3 years ago
* * $ANCN Video Chart 03-16-2021 * *

Link to Video - click here to watch the technical chart video

πŸ‘οΈ0
Jconwon Jconwon 3 years ago
Opened at 5.60 and pushed past and then rejected. Re-test of the 5.60 after pullback to 6.75. 22% I guess those longer wicks dont matter the later the day?
πŸ‘οΈ0
ClayTrader ClayTrader 3 years ago
* * $ANCN Video Chart 03-08-2021 * *

Link to Video - click here to watch the technical chart video

πŸ‘οΈ0
ClayTrader ClayTrader 4 years ago
* * $ANCN Video Chart 02-10-2021 * *

Link to Video - click here to watch the technical chart video

πŸ‘οΈ0
ClayTrader ClayTrader 4 years ago
* * $ANCN Video Chart 12-15-2020 * *

Link to Video - click here to watch the technical chart video

πŸ‘οΈ0
Cubanwinner Cubanwinner 4 years ago
Patience for all who buy weeks and weeks ago!!!
CONGRATULATIONS ALL BAG HOLDERS!!
πŸ‘οΈ0
Jess070283 Jess070283 4 years ago
Show me the money!$$$$ Patience pays off!!!!
πŸ‘οΈ0
Flanker7 Flanker7 4 years ago
Higher lows creating bullish ascending triangle, any mouse squeak of news or PR might skyrocket this low floater...again
πŸ‘οΈ0
sanderburwil sanderburwil 4 years ago
New CEO- Russian money backing this- mega merger
πŸ‘οΈ0
sanderburwil sanderburwil 4 years ago
Something sure is cooking
πŸ‘οΈ0
Flanker7 Flanker7 4 years ago
Chart and L2looking interesting again
πŸ‘οΈ0
Jess070283 Jess070283 4 years ago
Pump it up!$$$
πŸ‘οΈ0
Jess070283 Jess070283 4 years ago
Loading this dip!$$$$
πŸ‘οΈ0
Timing101 Timing101 4 years ago
ANCN... shorters.. they will have to cover
πŸ‘οΈ0
Timing101 Timing101 4 years ago
New CEO Neil Cohen... maker and shaker of companies.. all good
--
Appointment of Neil Cohen as CEO



On October 20, 2020, Anchiano Therapeutics Ltd. (the β€œCompany”) appointed Neil Cohen, age 57, as Chief Executive Officer of the Company, effective immediately. Pursuant to his employment agreement, in his capacity as Chief Executive Officer of the Company Mr. Cohen will receive a gross salary of $12,000 per month. Mr. Cohen will continue to serve as a member of the Company’s board of directors (the β€œBoard”).



Mr. Cohen has served as the Chairman and Chief Executive Officer of Castel Partners Ltd. since January 2012. In 1994, he co-founded Israel Seed Partners, a leading venture capital firm, and managed the firm until 2019. Mr. Cohen has invested in and served on the boards of directors of many private technology companies, including a large number which were acquired or completed successful initial public offerings, including Compugen (Nasdaq: CGEN), Shopping.com (Nasdaq: SHOP, acquired by EBAY), Broadlight (acquired by Broadcom, Nasdaq: AVGO) and Cyota (acquired by RSA). He is a venture partner at SKY, an Israeli middle-market private equity firm, at Hetz Ventures Management Ltd., an early-stage Israeli venture capital fund, and Shavit Capital. Mr. Cohen was previously the Business Editor of The Jerusalem Post and began his career in the private equity group at the Rothschild Bioscience Unit of N M Rothschild & Sons Limited in London. Mr. Cohen received a B.A. and M.A., with first class honors, from Oxford University.



Mr. Cohen is not a party to any agreement or transaction that would require disclosure under Item 404(a) of Regulation S-K. There are no family relationships between Mr. Cohen and any other director or executive officer of the Company that would require disclosure under Items 401(d) or 404(a) of Regulation S-K.
πŸ‘οΈ0
Timing101 Timing101 4 years ago
$ANCN... on many watch lists for Wed.. EP's Entry Point, Exit Point
and RE.. Re Entry today was huge.
--
Nice
--
8-K new CEO .. proven track record
$ANCN... 8-kFiled today after close... keep this on watch for WED Market.
https://www.otcmarkets.com/filing/html?id=14449576&guid=fZ_eU6LweVbdW3h
πŸ‘οΈ0
otcmoneydoubler otcmoneydoubler 4 years ago
GREAT NEWS. ANCN SHOULD BE A GOOD WATCH FOR TONIGHT AND TOMORROW. GONE FOR THE NIGHT, WEI HAS MADE MY DAY.
πŸ‘οΈ0
Flanker7 Flanker7 4 years ago
8K out http://archive.fast-edgar.com/20201020/A9BZV22D8C22U9ZU222T2ZZZB22DZ2Q2ZV22/
πŸ‘οΈ0
Timing101 Timing101 4 years ago
yep ... volume today ...
πŸ‘οΈ0
Flanker7 Flanker7 4 years ago
Juuuust a bit of volume today
πŸ‘οΈ0
swingingRichard swingingRichard 4 years ago
πŸ‘οΈ0
0210 0210 4 years ago
Nice pop to 0.96...looks "similiar" drop with cbl 52-wk low @0.18 yesterday. trade opp ahead...IF not, let's see what ANCN's new mgt got.
πŸ‘οΈ0
0210 0210 4 years ago
Trade opp ahead...let's see what ANCN's new mgt got.
πŸ‘οΈ0
FreeBird FreeBird 4 years ago
Looking into this, what's your speculation?
Unbelievable drop
πŸ‘οΈ0
0210 0210 4 years ago
80s - hi 70s. MC $30m 50% cash, hmmmm...
πŸ‘οΈ0
0210 0210 4 years ago
A/S 100m O/S 37.1m Mkt Cap: $50m. Nasdaq IPO: $11.50 on 02/2019.
πŸ‘οΈ0